Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Thyroid Eye Disease Treatment Market (2023 Edition)” which provides a complete analysis of the global Thyroid Eye Disease Treatment industry in terms of market segmentation by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, Other Therapeutics), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel), By Region and By Country. The market has been assessed for the historical period of 2018-2022, the estimates of 2023 and the forecast period of 2024-2029.



The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research also analyzes growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Thyroid Eye Disease Treatment market is expected to grow at a CAGR of 13.24%. The Global Thyroid Eye Disease Treatment Market is expected to generate USD 8.24 Billion by the end of 2029, up from USD 3.46 Billion in 2022.

The market for treatments of thyroid eye disease (TED) is witnessing substantial expansion as a result of the increasing prevalence of this ailment. Graves' disease, a prevalent autoimmune illness that affects the thyroid gland, is frequently linked to TED (thyroid eye disease). The prevalence of autoimmune disorders, such as Graves' disease, is on the rise, leading to a corresponding increase in the number of cases of thyroid eye disease (TED). The expansion of the patient population contributes to the increasing demand for TED treatments.

The introduction of biologic pharmaceuticals and targeted therapies is altering the landscape of TED treatment. In clinical trials, monoclonal antibodies that target specific immune response molecules, such as the IL-6 receptor and IGF-1 receptor, have demonstrated potential. These biologics can assist in modulating the immune response, reducing inflammation, and relieving TED symptoms. The development of these specialized treatments offers patients with mild to severe TED new treatment options.



Scope of the Report

• The report analyses the Thyroid Eye Disease Treatment Market by Value (USD Million).

• The report presents the analysis of Thyroid Eye Disease Treatment Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Thyroid Eye Disease Treatment Market by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins).

• The report analyses the Thyroid Eye Disease Treatment Market By Route of Administration (Oral, Parenteral, Topical)

• The report analyses the Thyroid Eye Disease Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channels).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Therapeutic Type, By Route of Administration and by Distribution Channels.

• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Horizon Therapeutics, GSK plc, Santen Pharmaceuticals, Viridian Therapeutics, Bioxcel Therapeutics, Novartis AG, Roche Holding AG, Sanofi, Teva Pharmaceuticals, Abbvie Inc.

ページTOPに戻る

Table of Contents

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Strategic Recommendations

3. Global Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)

3.1 Clinical Signs Of Thyroid Eye Disease

3.2 Signs and symptoms due to excess thyroid hormones

3.3 Global Thyroid Eye Disease Treatment Market: Dashboard

3.4 Global Thyroid Eye Disease Treatment Market: Market Value Assessment, 2018-2028 (USD Million)

3.5 Impact of COVID-19 on Global Thyroid Eye Disease Treatment Market

3.6 Global Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type

3.6.1 Global Thyroid Eye Disease Treatment Market, By Therapeutic Type Type Overview

3.6.2 Global Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)

3.6.3 Global Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)

3.6.4 Global Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)

3.6.5 Global Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)

3.7 Global Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration

3.7.1 Global Thyroid Eye Disease Treatment Market, By Route of Administration Overview

3.7.2 Global Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)

3.7.3 Global Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)

3.7.4 Global Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)

3.8 Global Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel

3.8.1 Global Thyroid Eye Disease Treatment Market, By Distribution Channel Overview

3.8.2 Global Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies By Value, 2018H-2028F (USD Million & CAGR)

3.8.3 Global Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

3.8.4 Global Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)



4. Global Thyroid Eye Disease Treatment Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)

5.1 Americas Thyroid Eye Disease Treatment Market: Snapshot

5.2 Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

5.3 Americas Thyroid Eye Disease Treatment Market: Key Factors

5.4 Americas Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type

5.4.1 Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview

5.4.2 Americas Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)

5.4.3 Americas Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)

5.4.4 Americas Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)

5.4.5 Americas Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)

5.5 Americas Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration

5.5.1 Americas Thyroid Eye Disease Treatment Market, By Route of Administration Overview

5.5.2 Americas Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)

5.5.3 Americas Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)

5.5.4 Americas Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)

5.6 Americas Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel

5.6.1 Americas Thyroid Eye Disease Treatment Market, By Distribution Channel Overview

5.6.2 Americas Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

5.6.3 Americas Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

5.6.4 Americas Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)

5.7 Americas Thyroid Eye Disease Treatment Market Segmentation: By Country

5.7.1 United States Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

5.7.1.1 United States Thyroid Eye Disease Treatment Market, By Therapeutic Type

5.7.1.2 United States Thyroid Eye Disease Treatment Market, By Route of Administration

5.7.1.3 United States Thyroid Eye Disease Treatment Market, By Distribution Channel

5.7.2 Canada Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

5.7.2.1 Canada Thyroid Eye Disease Treatment Market, By Therapeutic Type

5.7.2.2 Canada Thyroid Eye Disease Treatment Market, By Route of Administration

5.7.2.3 Canada Thyroid Eye Disease Treatment Market, By Distribution Channel

5.7.3 Rest of Americas Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

5.7.3.1 Rest of Americas Thyroid Eye Disease Treatment Market, By Therapeutic Type

5.7.3.2 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration

5.7.3.3 Rest of Americas Thyroid Eye Disease Treatment Market, By Route of Administration



6. Europe Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)

6.1 Europe Thyroid Eye Disease Treatment Market: Snapshot

6.2 Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.3 Europe Thyroid Eye Disease Treatment Market: Key Factors

6.4 Europe Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type

6.4.1 Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview

6.4.2 Europe Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)

6.4.3 Europe Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)

6.4.4 Europe Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)

6.4.5 Europe Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)

6.5 Europe Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration

6.5.1 Europe Thyroid Eye Disease Treatment Market, By Route of Administration Overview

6.5.2 Europe Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)

6.5.3 Europe Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)

6.5.4 Europe Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)

6.6 Europe Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel

6.6.1 Europe Thyroid Eye Disease Treatment Market, By Distribution Channel Overview

6.6.2 Europe Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

6.6.3 Europe Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

6.6.4 Europe Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)

6.7 Europe Thyroid Eye Disease Treatment Market Segmentation: By Country

6.7.1 Germany Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.1.1 Germany Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.1.2 Germany Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.1.3 Germany Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.2 United Kingdom Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.2.1 United Kingdom Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.2.2 United Kingdom Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.2.3 United Kingdom Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.3 France Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.3.1 France Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.3.2 France Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.3.3 France Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.4 Italy Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.4.1 Italy Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.4.2 Italy Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.4.3 Italy Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.5 Spain Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.5.1 Spain Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.5.2 Spain Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.5.3 Spain Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel

6.7.6 Rest of Europe Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

6.7.6.1 Rest of Europe Thyroid Eye Disease Treatment Market, By Therapeutic Type

6.7.6.2 Rest of Europe Thyroid Eye Disease Treatment Market, By Route of Administration

6.7.6.3 Rest of Europe Thyroid Eye Disease Treatment Market, By Distribution Channel



7. Asia-Pacific Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)

7.1 Asia-Pacific Thyroid Eye Disease Treatment Market: Snapshot

7.2 Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

7.3 Asia-Pacific Thyroid Eye Disease Treatment Market: Key Factors

7.4 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type

7.4.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview

7.4.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)

7.4.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)

7.4.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)

7.4.5 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)

7.5 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration

7.5.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration Overview

7.5.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)

7.5.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)

7.5.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)

7.6 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel

7.6.1 Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel Overview

7.6.2 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

7.6.3 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

7.6.4 Asia-Pacific Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)

7.7 Asia-Pacific Thyroid Eye Disease Treatment Market Segmentation: By Country

7.7.1 China Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

7.7.1.1 China Thyroid Eye Disease Treatment Market, By Therapeutic Type

7.7.1.2 China Thyroid Eye Disease Treatment Market, By Route of Administration

7.7.1.3 China Thyroid Eye Disease Treatment Market, By Distribution Channel

7.7.2 Japan Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

7.7.1.1 Japan Thyroid Eye Disease Treatment Market, By Therapeutic Type

7.7.1.2 Japan Thyroid Eye Disease Treatment Market, By Route of Administration

7.7.1.3 Japan Thyroid Eye Disease Treatment Market, By Distribution Channel

7.7.3 India Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

7.7.3.1 India Thyroid Eye Disease Treatment Market, By Therapeutic Type

7.7.3.2 India Thyroid Eye Disease Treatment Market, By Route of Administration

7.7.3.3 India Thyroid Eye Disease Treatment Market, By Distribution Channel

7.7.5 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

7.7.5.1 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Therapeutic Type

7.7.5.2 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Route of Administration

7.7.5.3 Rest of Asia-Pacific Thyroid Eye Disease Treatment Market, By Distribution Channel



8. Middle-East & Africa Thyroid Eye Disease Treatment Market: Historic and Forecast (2018-2028)

8.1 Middle-East & Africa Thyroid Eye Disease Treatment Market: Snapshot

8.2 Middle-East & Africa Thyroid Eye Disease Treatment Market: Market Size and CAGR, 2018-2028 (USD Million & CAGR)

8.3 Middle-East & Africa Thyroid Eye Disease Treatment Market: Key Factors

8.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Therapeutic Type

8.4.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Therapeutic Type Overview

8.4.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Monoclonal Antibodies, By Value, 2018H-2028F (USD Million & CAGR)

8.4.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Corticosteroids, By Value, 2018H-2028F (USD Million & CAGR)

8.4.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Vitamins, By Value, 2018H-2028F (USD Million & CAGR)

8.4.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Other Therapeutics, By Value, 2018H-2028F (USD Million & CAGR)

8.5 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Route of Administration

8.5.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Route of Administration Overview

8.5.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Oral, By Value, 2018H-2028F (USD Million & CAGR)

8.5.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Parenteral, By Value, 2018H-2028F (USD Million & CAGR)

8.5.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Topical, By Value, 2018H-2028F (USD Million & CAGR)

8.6 Middle-East & Africa Thyroid Eye Disease Treatment Market Segmentation: By Distribution Channel

8.6.1 Middle-East & Africa Thyroid Eye Disease Treatment Market, By Distribution Channel: Overview

8.6.2 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Hospital Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

8.6.3 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Retail Pharmacies, By Value, 2018H-2028F (USD Million & CAGR)

8.6.4 Middle-East & Africa Thyroid Eye Disease Treatment Market Size, By Online Channel, By Value, 2018H-2028F (USD Million & CAGR)



9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on the Global Thyroid Eye Disease Treatment Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Porter’s Five Forces Analysis

10.1 Porter’s Five Forces Model



11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Thyroid Eye Disease Treatment Market

11.4 Company Profiles

11.4.1 Horizon Therapeutics

11.4.2 GSK plc

11.4.3 Santen Pharmaceuticals

11.4.4 Viridian Therapeutics

11.4.5 Bioxcel Therapeutics

11.4.6 Novartis AG

11.4.7 Roche Holding AG

11.4.8 Sanofi

11.4.9 Teva Pharmaceuticals

11.4.10 Abbvie Inc